The Role of Decoy Receptor DcR3 in Gastrointestinal Malignancy.
Ontology highlight
ABSTRACT: Malignancies are among the leading causes of mortality worldwide. Early detection and treatment are the primary targets of clinical and translational research, and may be facilitated by the recognition of novel diagnostic and prognostic biomarkers. Decoy receptor 3 (DcR3) is a soluble receptor of the tumor necrosis factor receptor superfamily of proteins (TNFRSF), which associates with its respective TNF-like ligands, Fas-L, LIGHT, and TL1A. DcR3 has been recognised as a significant anti-apoptotic factor with prominent involvement in various inflammatory and neoplastic conditions. Increased intratumor expression of DcR3 and elevated soluble DcR3 protein content in the sera of patients has been reported for various malignancies. Recent published work has suggested that monitoring of local a
SUBMITTER: Lagou S
PROVIDER: S-EPMC9254098 | biostudies-literature | 2022 Jul-Aug
REPOSITORIES: biostudies-literature
ACCESS DATA